Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Meridian Bioscience Inc (NASDAQ:VIVO)

19.41
Delayed Data
As of Feb 10
 -0.02 / -0.10%
Today’s Change
16.60
Today|||52-Week Range
21.23
-5.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues173.5M188.7M188.8M194.8M
 
 
 
 
 
Cost of Goods Sold57.9M60.5M66.0M66.3M
 
 
 
 
 
Depreciation And Amortization6.6M7.2M5.6M6.6M
 
 
 
 
 
 
Operating ExpensesGross Income109.0M121.0M117.2M121.9M
 
 
 
 
 
General Expenses58.7M63.7M64.9M65.8M
 
 
 
 
 
Research And Development10.3M10.8M12.6M12.6M
 
 
 
 
 
Total Operating Expenses123.2M131.4M136.4M138.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income50.3M57.3M52.4M56.1M
 
 
 
 
 
Extraordinary Charge-1.0M0.00--0.00
 
 
Other Expenses378.0K4.0K-309.0K-1.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income49.7M57.4M52.1M55.1M
 
 
 
 
 
Income Taxes-16.3M-19.3M-17.4M-19.5M
 
 
 
 
 
Net Income33.4M38.0M34.7M35.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.1M41.2M41.5M41.7M
 
 
 
 
 
Shares To Calculate EPS Diluted41.6M41.9M41.9M42.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.80$0.91$0.83$0.85
 
 
 
 
 
EPS Diluted$0.80$0.91$0.83$0.85